Undiagnosed hypertrophic obstructive cardiomyopathy during transcatheter aortic valve replacement: A case report

被引:9
|
作者
Olsen K.R. [1 ]
Lagrew J.E. [1 ]
Awoniyi C.A. [1 ,2 ]
Goldstein J.C. [1 ,2 ]
机构
[1] Department of Anesthesiology, University of Florida, College of Medicine, Gainesville, FL
[2] North Florida/South Georgia Veterans Affairs Medical Center, 1601 SW Archer Road, Gainesville, 32608, FL
关键词
Aortic stenosis; Hypertrophic obstructive cardiomyopathy; TAVR; Transcatheter aortic valve replacement;
D O I
10.1186/s13256-018-1904-8
中图分类号
学科分类号
摘要
Background: Transcatheter aortic valve replacement is indicated for severe symptomatic aortic stenosis in patients who have a very high or prohibitive surgical risk as assessed pre-procedurally by the Society of Thoracic Surgery Risk Score, EuroSCORE (II), frailty testing, and other predictors. When combined with another left ventricular outflow tract obstruction, careful consideration must be taken prior to proceeding with transcatheter aortic valve replacement because an additional masked left ventricular outflow tract pathology can lead to challenging hemodynamics in the peri-deployment phase, as reported in this case. Case presentation: A 56-year-old Caucasian man with multiple comorbidities and severe aortic stenosis underwent transcatheter aortic valve replacement under monitored anesthesia care. During the deployment phase, he developed dyspnea that progressed to pulmonary edema requiring emergent conversion to general anesthesia, orotracheal intubation, acute respiratory distress syndrome-type ventilation, and vasopressor medications. Intraoperative transesophageal echocardiography was performed and hypertrophic obstructive cardiomyopathy with systolic anterior motion of the mitral valve was discovered as an underlying pathology, undetected on preoperative imaging. After treatment with beta blockers, fluid resuscitation, and alpha-1 agonists, he stabilized and was eventually discharged from our hospital without any lasting sequelae. Conclusions: Patients with aortic stenosis most often develop symmetric hypertrophy; however, a small subset has asymmetric septal hypertrophy leading to left ventricular outflow tract obstruction. In cases of severe aortic stenosis, however, evidence of left ventricular outflow tract obstruction via both symptoms and echocardiographic findings may be minimized due to extremely high afterload on the left ventricle. Diagnosing a left ventricular outflow tract obstruction as the cause of hemodynamic instability during transcatheter aortic valve replacement, in the absence of abnormal findings on echocardiogram preoperatively, requires a high index of clinical suspicion. The management of acute onset left ventricular outflow tract obstruction intraoperatively consists primarily of medical therapy, including rate control, adequate volume resuscitation, and avoidance of inotropes. With persistently elevated gradients, interventional treatments may be considered. © 2018 The Author(s).
引用
收藏
相关论文
共 50 条
  • [21] Mitral valve replacement and septal myectomy for hypertrophic obstructive cardiomyopathy
    Furukawa K.
    Hayase T.
    Yano M.
    General Thoracic and Cardiovascular Surgery, 2014, 62 (3) : 181 - 183
  • [22] Mitral valve replacement at time of myectomy for hypertrophic obstructive cardiomyopathy
    Singh, A.
    Agrawal, S.
    Saluja, S.
    Pakniyat, S.
    Manda, Y.
    Nanda, S.
    Shirani, J.
    EUROPEAN HEART JOURNAL, 2017, 38 : 462 - 462
  • [23] OPERATIVE TREATMENT OF HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY - CASE AGAINST MITRAL-VALVE REPLACEMENT
    ROBERTS, WC
    AMERICAN JOURNAL OF CARDIOLOGY, 1973, 32 (03): : 377 - 381
  • [24] Renal Transplantation after Transcatheter Aortic Valve Replacement: Case Report
    Gangadharan, Keerthana
    Parameswaranunni, Reshmibhat
    Merzkani, Massini
    Molmenti, Ernesto
    Bhaskaran, Madhu
    INTERNATIONAL JOURNAL OF ANGIOLOGY, 2020, 29 (01) : 55 - 57
  • [25] NAVIGATING THE CHALLENGES OF TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR): A CASE REPORT
    Menon, Tushar
    Mistry, Ameera
    CHEST, 2024, 166 (04) : 218A - 218A
  • [26] Congenital quadricuspid aortic valve associated with obstructive hypertrophic cardiomyopathy
    Nucifora, Gaetano
    Badano, Luigi P.
    Iacono, Maria A.
    Fazio, Grazia
    Cinelllo, Margherita
    Marinigh, Ricarda
    Fioretti, Paolo M.
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2008, 9 (03) : 317 - 318
  • [27] ONE IS THE LONELIEST NUMBER - A RARE CASE OF UNICUSPID AORTIC VALVE AND HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
    Maheshwari, Tania
    Tran, Daniel C.
    Palli, Vasu
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 3123 - 3123
  • [28] Transaxillary Transcatheter Aortic Valve Replacement in a Patient With Previous Aortic Valve-Sparing Root Replacement: A Case Report
    EL-Andari, Ryaan
    Bozso, Sabin J.
    Kang, Jimmy J. H.
    Baghaffar, Abdullah
    Berube, Joel
    Moon, Michael C.
    Tyrrell, Benjamin D.
    Mathew, Anoop
    Welsh, Robert C.
    Nagendran, Jeevan
    CJC OPEN, 2023, 5 (03) : 233 - 236
  • [29] HYPERTROPHIC CARDIOMYOPATHY (HOCM) FOLLOWING AORTIC-VALVE REPLACEMENT
    THOMPSOM, R
    YACOUB, M
    NEW ZEALAND MEDICAL JOURNAL, 1980, 91 (659) : 362 - 362
  • [30] Transcatheter Aortic Valve Replacement During Pregnancy
    Hodson, Robert
    Kirker, Eric
    Swanson, Jeffrey
    Walsh, Craig
    Korngold, Ethan C.
    Ramelli, Sarah
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (10)